HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the ...

Speaking exclusively to Newsweek, parents Edna and Tony shared they will 'gladly' explain to their seven-month-old son the ...

Gay men in Nigeria said that they tested positive for HIV two months after losing access to a US-supplied drug that ...

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

Winnie Byanyima says her organization has lost almost 50% of its funding, a gap that is undermining global efforts to combat ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

Emmanuel Cherem, a 25-year-old gay man in Nigeria, tested positive for HIV two months after U.S. President Donald Trump's ...

On Wednesday, the Food and Drug Administration approved a highly effective, injectable drug to help prevent the transmission ...

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Pharmaceutical company Gilead Sciences announced Wednesday the Food and Drug Administration (FDA) has approved its six-month, twice-yearly HIV PrEP injection, which was found in trials to be more ...